FDA approves first treatment for activated phosphoinositide 3-kinase delta syndrome

FDA · Mar 25, 2023

FDA has approved Joenja (leniolisib) tablets as the first treatment for activated phosphoinositide 3-kinase delta syndrome in adult and pediatric patients 12 years of age and older.

Baca selengkapnya di : http://www.fda.gov...

FDA approves first treatment for activated phosphoinositide 3-kinase delta syndrome

FDA

Guest